Rosuvastatin calcium is a highly potent, relatively hydrophilic HMG-CoA reductase inhibitor (statin) featuring an advanced binding affinity for the target enzyme. By fully blocking the mevalonate synthesis pathway in hepatocytes, it triggers a dramatic clearance of low-density lipoprotein cholesterol (LDL-C) from the bloodstream. This intensive lipid-modulating action corrects dyslipidemia, optimizes high-density lipoprotein (HDL) profiles, and systematically alters the arterial microenvironment to retard the progression of calcified plaques.